摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

仲-丁基异丙基醚 | 18641-81-1

中文名称
仲-丁基异丙基醚
中文别名
——
英文名称
isopropyl sec-butyl ether
英文别名
Sec-butyl isopropyl ether;2-propan-2-yloxybutane
仲-丁基异丙基醚化学式
CAS
18641-81-1
化学式
C7H16O
mdl
——
分子量
116.203
InChiKey
QHJLNXCHSKDYHR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    -95.35°C (estimate)
  • 沸点:
    117.3°C (estimate)
  • 密度:
    0.7684 (estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    8
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2909199090

SDS

SDS:844f7a99f9cc3819a41a1d1b7ae6e1fb
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    JOSIDA, SIDZUO;XOSOGAVA, TOSIXIRO;KOKUBO, MASAXIRO;KAMIYAMA, SEHTSUO;KOYA+
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    MEHTA R. K. S., INDIAN J. CHEM., 25,(1986) N 2, 157-161
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • TRICYCLIC SULFONAMIDE DERIVATIVES
    申请人:CHEN Shuhui
    公开号:US20150183802A1
    公开(公告)日:2015-07-02
    The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.
    本发明涉及公式(I)的衍生物,其中取代基如规范中定义;制备这种衍生物的过程;包括这种衍生物的药物组合物;将这种衍生物用作药物;将这种衍生物用于治疗疼痛。
  • METHOD FOR PRODUCING N-METHYL-N-VINYLACETAMIDE HAVING IMPROVED STABILITY AND POLYMERIZABILITY
    申请人:Showa Denko K.K.
    公开号:EP2239250A1
    公开(公告)日:2010-10-13
    The present invention relates to a method for producing N-methyl-N-vinylacetamide, which comprises a step for controlling the N-1,3-butadienyl-N-methylacetamide content in N-methyl-N-vinylacetamide to 0.01-150 ppm. This method enables production of N-methyl-N-vinylacetamide having a stable quality, which can be controlled in stability and polymerizability as a monomer. N-methyl-N-vinylacetamide produced by the method enables production of an N-methyl-N-vinylacetamide polymer having stable physical properties such as a molecular weight.
    本发明涉及一种生产N-甲基-N-乙烯基乙酰胺的方法,其中包括控制N-1,3-丁二烯基-N-甲基乙酰胺在N-甲基-N-乙烯基乙酰胺中的含量为0.01-150 ppm的步骤。该方法使得能够生产具有稳定质量的N-甲基-N-乙烯基乙酰胺,可以在稳定性和聚合性作为单体中进行控制。通过该方法生产的N-甲基-N-乙烯基乙酰胺能够生产具有稳定物理性质,如分子量的N-甲基-N-乙烯基乙酰胺聚合物。
  • RESIST POLYMER, RESIST COMPOSITION, PROCESS FOR PATTERN FORMATION, AND STARTING COMPOUNDS FOR PRODUCTION OF THE RESIST POLYMER
    申请人:Momose Hikaru
    公开号:US20090198065A1
    公开(公告)日:2009-08-06
    To provide a resist polymer comprising, as a structural unit, an acid-decomposable unit having a structure represented by formula (1) or (2) which exhibits a small line edge roughness and produces little defects in DUV excimer laser lithography or the like. In formulas (1) and (2), n represents an integer of 2 to 24; J represents a single bond or a divalent hydrocarbon group which may have a substituent/heteroatom when n=2, or represents an n-valent hydrocarbon group which may have a substituent/heteroatom when n≧3; E represents a residue of a polymerization terminator, a chain transfer agent or a polymerization initiator; K 1 and K 2 each represent at least one selected from alkylene, cycloalkylene, oxyalkylene, arylene, a divalent thiazoline ring, a divalent oxazoline ring and a divalent imidazoline ring; L 1 and L 2 each represent at least one selected from —C(O)O—, —C(O)— and —OC(O)—; M 1 , M 2 and M 3 each represent at least one selected from alkylene, cycloalkylene, oxyalkylene and arylene; Y, Y 1 and Y 2 each represent an acid-decomposable linkage; k1, k2, l1, l2, m1, m2, and m3 each represent 0 or 1; and R 1 represents H or a methyl group.
    提供一种抗蚀聚合物,其由一个具有结构式(1)或(2)所表示的酸分解单元作为结构单元,能够在DUV准分子激光微影或类似工艺中表现出小的线边粗糙度并产生少量缺陷。在式(1)和(2)中,n表示2至24的整数;J表示单键或二价碳氢基团,当n=2时可以具有取代基/杂原子,或者当n≥3时可以表示n价碳氢基团,可以具有取代基/杂原子;E表示聚合终止剂、链转移剂或聚合引发剂的残基;K1和K2分别表示至少选择自烷基、环烷基、氧烷基、芳烃、二价噻唑环、二价噁唑环和二价咪唑环中的至少一种;L1和L2分别表示至少选择自—C(O)O—、—C(O)—和—OC(O)—中的至少一种;M1、M2和M3分别表示至少选择自烷基、环烷基、氧烷基和芳烃中的至少一种;Y、Y1和Y2分别表示酸分解键;k1、k2、l1、L2、m1、m2和m3分别表示0或1;R1表示H或甲基基团。
  • PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY
    申请人:Cannizzaro Carina
    公开号:US20090227543A1
    公开(公告)日:2009-09-10
    The invention is related to phosphonate substituted compounds having immuno-modulatory activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    本发明涉及磷酸酯取代化合物,具有免疫调节活性,含有这种化合物的组合物,以及包括这种化合物的给药的治疗方法,还涉及用于制备这种化合物的有用过程和中间体。
  • ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
    申请人:Cannizzaro Carina
    公开号:US20090247488A1
    公开(公告)日:2009-10-01
    The invention is related to phosphorus substituted anti-inflammatory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    本发明涉及取代的抗炎化合物、含有这种化合物的组合物、包括给药这种化合物的治疗方法,以及用于制备这种化合物的有用过程和中间体。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台